Cochlear Ltd (COH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cochlear Ltd (COH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7295
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions. It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage. Its major products include cochlear implant systems, bone conduction systems, acoustic implants, bone anchored prosthetics and wireless accessories including wireless mini microphone, wireless phone clip and wireless TV streamer. It has manufacturing facilities and regional distribution centers in North America and Europe. The company conducts its operations in the Americas, Asia-Pacific, the Middle East and Europe. The company markets its products through subsidiaries, local offices, distributors and agents. Cochlear is headquartered in Lane Cove, New South Wales, Australia.

Cochlear Ltd (COH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cochlear Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cochlear Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cochlear Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cochlear Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cochlear Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cochlear Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Earlens Raises USD34 Million in First Tranche of Series C Financing 10
Partnerships 12
Sensorion Enters into Partnership Agreement with Cochlear 12
GN ReSound Enters into Co-Development Agreement with Cochlear 13
Equity Offering 14
Earlens Raises USD73 Million in Private Placement of Series C Preferred Shares 14
Cochlear Ltd – Key Competitors 16
Cochlear Ltd – Key Employees 17
Cochlear Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 22
Strategy And Business Planning 22
Feb 27, 2018: Cochlear and The Royal Victorian Eye and Ear Hospital Open the Geelong Cochlear Care Centre – a first for Regional 22
Financial Announcements 23
Aug 17, 2017: Cochlear Announces Financial Results for year Ended June 2017 23
Corporate Communications 30
Aug 13, 2018: Cochlear announces Prof Edward Byrne, AC’s intention to retire 30
Jul 31, 2017: Cochlear: Chief Executive Officer & President Transition Timeline Announced 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Cochlear Ltd, Medical Equipment, Key Facts, 2018 2
Cochlear Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cochlear Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cochlear Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cochlear Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cochlear Ltd, Deals By Market, 2012 to YTD 2018 8
Cochlear Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Earlens Raises USD34 Million in First Tranche of Series C Financing 10
Sensorion Enters into Partnership Agreement with Cochlear 12
GN ReSound Enters into Co-Development Agreement with Cochlear 13
Earlens Raises USD73 Million in Private Placement of Series C Preferred Shares 14
Cochlear Ltd, Key Competitors 16
Cochlear Ltd, Key Employees 17
Cochlear Ltd, Other Locations 18
Cochlear Ltd, Subsidiaries 18

List of Figures
Cochlear Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cochlear Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cochlear Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cochlear Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cochlear Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cochlear Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cochlear Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cochlear Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cochlear Ltd (COH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Epic Systems Corp:企業の戦略的SWOT分析
    Epic Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Synthos SA:企業の戦略的SWOT分析
    Synthos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Vascular Biogenics Ltd (VBLT):企業の財務・戦略的SWOT分析
    Summary Vascular Biogenics Ltd (VBL Therapeutics) is a biopharmaceutical company. It discovers, develops and commercializes gene-therapy medicines for the treatment of cancer and inflammatory diseases. The company’s lead product candidate VB-111, a gene-based biologic agent is developed to treat rec …
  • China Longyuan Power Group Corp Ltd (916):企業の財務・戦略的SWOT分析
    China Longyuan Power Group Corp Ltd (916) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Deluxe Corporation:企業の戦略・SWOT・財務分析
    Deluxe Corporation - Strategy, SWOT and Corporate Finance Report Summary Deluxe Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Want Want China Holdings Limited:企業の戦略・SWOT・財務情報
    Want Want China Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Want Want China Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • XState Resources Ltd (XST):石油・ガス:M&Aディール及び事業提携情報
    Summary XState Resources Ltd (XState Resources) is an oil and gas exploration and development company. The company’s business activities include acquisition, exploration, production and development of oil and gas assets. It holds interest in producing gas wells and associated land leases and product …
  • Amcor Limited:企業の戦略・SWOT・財務分析
    Amcor Limited - Strategy, SWOT and Corporate Finance Report Summary Amcor Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ausgrid:企業の戦略的SWOT分析
    Ausgrid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Mednax Inc (MD):製薬・医療:M&Aディール及び事業提携情報
    Summary Mednax Inc (Mednax) is a national medical group company, which operates a network of physician service providers. The company offers a wide range of neonatal, anesthesia, maternal-fetal, pediatric physician and subspecialty services. Its network includes other pediatric subspecialists compri …
  • TearLab Corp (TEAR):製品パイプライン分析
    Summary TearLab Corp (TearLab) is an ophthalmic device company. It commercializes a proprietary in vitro diagnostic tear testing platform. The company’s flagship TearLab osmolarity system measures the osmolarity of human tears to aid in the diagnosis of dry eye disease (DED) in patients. Its osmolar …
  • Mindteck (India) Limited:戦略・SWOT・企業財務分析
    Mindteck (India) Limited - Strategy, SWOT and Corporate Finance Report Summary Mindteck (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Tosoh Corporation:企業の戦略・SWOT・財務情報
    Tosoh Corporation - Strategy, SWOT and Corporate Finance Report Summary Tosoh Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Albumedix AS-製薬・医療分野:企業M&A・提携分析
    Summary Albumedix A/S (Albumedix), a subsidiary of Novozymes A/S, is a developer of albumin-based products and technologies for advanced drug and vaccine formulation, extended drug half-life and improved drug delivery. Its product Recombumin is a recombinant human albumin used in the manufacture of …
  • Canada Energy Partners Inc (CE):石油・ガス:M&Aディール及び事業提携情報
    Summary Canada Energy Partners Inc (Canada Energy) is a natural gas exploration and development company. The company concentrates on mid-stream supplying of water disposal services, development of a wellbore mining technology and energy or mineral exploring. It develops a wellbore mining technology …
  • P. H. Glatfelter Co (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Co (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sime Darby Berhad (SIME)-エネルギー分野:企業M&A・提携分析
    Summary Sime Darby Berhad (Sime Darby) is a trading and logistics company. It operates as a conglomerate that provides diversified products and services through its subsidiaries, affiliates, and joint ventures. The company cultivates oil palm, rubber, sugar cane, and cattle rearing and produces oil …
  • Jindal Steel & Power Ltd:企業の戦略・SWOT・財務情報
    Jindal Steel & Power Ltd - Strategy, SWOT and Corporate Finance Report Summary Jindal Steel & Power Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Thermo Fisher Scientific Inc (TMO):医療機器:M&Aディール及び事業提携情報
    Summary Thermo Fisher Scientific Inc (Thermo Fisher) is a provider of equipment, analytical instruments, reagents and consumables, software and services to tackle complex analytical challenges in research, diagnostics and clinical laboratories. It offers solutions for cellular analysis and biology, …
  • Medical Prognosis Institute A/S (MPI):企業の財務・戦略的SWOT分析
    Summary Medical Prognosis Institute A/S (MPI) is a precision medicine provider that offers cancer treatment solutions. The company offers drug response prediction platforms that provide tools for rationalized drug development and personalized medicine. It offers lead compound selection, drug rescue …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆